Ultra high-speed OCT provides minute structural details, potential applications

Article

Ultra high-speed optical coherence tomography (OCT) offers the potential to follow minute changes in patients with various pathologies. Johannes de Boer, PhD, the Wellman Center of Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, reviewed the principles of OCT and the status of ultra high-speed OCT.

Ultra high-speed optical coherence tomography (OCT) offers the potential to follow minute changes in patients with various pathologies. Johannes de Boer, PhD, the Wellman Center of Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, reviewed the principles of OCT and the status of ultra high-speed OCT.

"OCT is analogous to ultrasound imaging that uses infrared light instead of sound-the difference between light and sound being that light propagates at five orders of a magnitude faster than sound," Dr. de Boer explained.

"Spectral domain offers a significant advantage over the previous-generation OCT because it provides two to three times better sensitivity," Dr. de Boer said. "Spectral domain OCT allows faster scanning and maintenance of image quality."

One of the first retinal images of 6-µm resolution obtained in the early 1990s provided a 72-fold improvement over the commercial system in speed and 1.5 times in depth resolution. One disadvantage is that the sensitivity of spectral domain OCT is depth-dependent, and the sensitivity decreases by a factor of four at a depth of 1 mm compared with Stratus OCT (Carl Zeiss Meditec), in which the depth response of the system is uniform and the sensitivity is the same. Swept-source OCT can overcome this drawback because the technique uses a laser to obtain the tissue profile.

Dr. de Boer described the potential clinical applications of the technology in glaucoma. He demonstrated that thinning of the superior nerve fiber bundle could be visualized. This may allow clinicians to follow patients with glaucoma over time and offers a comparison of the retinal nerve fiber layer thinning from one time point to another on difference maps.

Clinical application also can be used in patients with age-related macular degeneration because blood clots, subretinal fluid, and suspected choroidal neovascularization can be imaged as well as the scattering of the photoreceptors-leading to a consideration of the changes in the scattering properties of the photoreceptors in these patients and whether these changes are indicative of photoreceptor survival.

Dr. de Boer said that there will be an emergence of increasingly fast OCT systems, but he believes that the technology is limited by the amount of light that is currently introduced into the eye and the resultant quality of the images. He suggested that adding more power in the retina in a shorter amount of time might be a solution.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.